Questionnaires
study tools in ophthalmology
DOI:
https://doi.org/10.70313/2718.7446.v16.n01.207Keywords:
questionnaires, PROM, VFQ, OSDI, quality of lifeAbstract
Questionnaires have become a great tool in medicine, both in the field of care and in research, since they make it possible to obtain patient-reported outcome measures. They are generally referred to as PROMs (patient-reported outcome measures). They make it possible to know the patient’s opinion on different aspects, but through the application of a specific methodology, they transform this “opinion” into a measurable parameter, which in turn becomes reproducible and comparable, whether for the same patient in different scenarios, or for comparing populations. But there are a series of characteristics that will make a questionnaire gain or lose scientific power. Something to consider, for example, are the socio-cultural conditions and the language of the population in which it will be applied. Among the PROMs most commonly used in ophthalmology, we find the VFQ-25 (which is the most commonly used in the different subspecialties to assess quality of life) and the OSDI, which has become popular as a good tool in the evaluation of patients with ocular surface problems. But sometimes, it may be necessary to adapt or even create questionnaires specifically designed for a special condition or study.
Downloads
References
Mercieca-Bebber R, King MT et al. The importance of patient-reported outcomes in clinical trials and strategies for future optimization. Patient Relat Outcome Meas 2018; 9: 353-367.
U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research; U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research; U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes 2006; 4: 79.
Wilson R. Patient led PROMs must take centre stage in cancer research. Research Involvement and Engagement 2018; 4: 7.
Wu AW, Snyder C. Getting ready for patient-reported outcomes measures (PROMs) in clinical practice. Health Pap 2011; 11: 48-53.
Patrick DL, Burke LB, Gwaltney CJ et al. Content validity: establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1: eliciting concepts for a new PRO instrument. Value Health 2011; 14: 967-977.
Braithwaite T, Calvert M, Gray A et al. The use of patient-reported outcome research in modern ophthalmology: impact on clinical trials and routine clinical practice. Patient Relat Outcome Meas 2019; 10: 9-24.
Mangione CM, Lee PP, National Eye Institute Visual Function Questionnaire Field Test Investigators et al. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol 2001; 119: 1050-1058.
Mangione CM, Lee PP, Pitts J et al. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators. Arch Ophthalmol 1998; 116: 1496-1504.
Cole SR, Beck RW, Moke PS et al. The National Eye Institute Visual Function Questionnaire: experience of the ONTT. Optic Neuritis Treatment Trial. Invest Ophthalmol Vis Sci 2000; 41: 1017-1021.
Gómez AL, Correa OI, Rodríguez V. Validación transcultural de la escala NEI VFQ-25 para la medición de la calidad de vida del paciente con alteraciones oculares en el Hospital Simón Bolívar. Rev Soc Colomb Oftalmol 2013; 46: 33-53.
Rand Health Care. Visual Function Questionnaire (VFQ-25). Santa Mónica, California: RAND Corporation, 1994-. Disponible en: http://www.rand.org/health/surveys_tools/vfq.html
Mangione CM. NEI VFQ-25 scoring algorithm. Rockville: National Eye Institute, 2000. Disponible en:
https://www.nei.nih.gov/sites/default/files/2019-06/manual_cm2000.pdf
Schiffman RM, Christianson MD, Jacobsen G et al. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol 2000; 118: 615-621.
Walt J, Rowe M, Stern K. Evaluating the functional impact of dry eye: the Ocular Surface Disease Index. Drug Inf J 1997; 31: 1436.
Ozcura F, Aydin S, Helvaci MR. Ocular surface disease index for the diagnosis of dry eye syndrome. Ocul Immunol Inflamm 2007; 15: 389-393.
Braithwaite T, Calvert M, Gray A et al. The use of patient-reported outcome research in modern ophthalmology: impact on clinical trials and routine clinical practice. Patient Relat Outcome Meas 2019; 10: 9-24.
Raphael BA, Galetta KM, Jacobs DA et al. Validation and test characteristics of a 10-item neuro-ophthalmic supplement to the NEI-VFQ-25. Am J Ophthalmol 2006; 142: 1026-1035.
Kotecha A, Feuer WJ, Tube Versus Trabeculectomy Study Group et al. Quality of life in the tube versus trabeculectomy study. Am J Ophthalmol 2017; 176: 228-235.
King AJ, Fernie G, Azuara-Blanco A et al. Treatment of advanced glaucoma study: a multicentre randomised controlled trial comparing primary medical treatment with primary trabeculectomy for people with newly diagnosed advanced glaucoma-study protocol. Br J Ophthalmol 2018; 102: 922-928.
Matsuoka Y, Tanito M, Takai Y et al. Visual function and vision-related quality of life after vitrectomy for epiretinal membranes: a 12-month follow-up study. Invest Ophthalmol Vis Sci 2012; 53: 3054-3058.
Samuelson TW, Singh IP, Williamson BK et al. quality of life in primary open-angle glaucoma and cataract: an analysis of VFQ-25 and OSDI from the iStent inject® pivotal trial. Am J Ophthalmol 2021; 229: 220-229.
Kirwan C, Lanigan B, O’Keefe M. Vision-related quality of life assessment using the NEI-VFQ-25 in adolescents and young adults with a history of congenital cataract. J Pediatr Ophthalmol Strabismus 2012; 49: 26-31.
Eser-Öztürk H, Yeter V, Karabekiroğlu A, Süllü Y. The effect of vision-related quality of life on depression and anxiety in patients with Behçet uveitis. Turk J Ophthalmol 2021; 51: 358-364.
Bertrand PJ, Jamilloux Y, Kodjikian L et al. Quality of life in patients with uveitis: data from the ULISSE study (Uveitis: clinical and medico-economic evaluation of a standardised strategy for the etiological diagnosis). Br J Ophthalmol 2021; 105: 935-940.
Fujiike K, Mizuno Y, Strabismus Surgery Study Group et al. Quality of life and cost-utility assessment after strabismus surgery in adults. Jpn J Ophthalmol 2011; 55: 268-276.
Prigol AM, Tenório MB, Matschinske R et al. Tradução e validação do índice da doença da superfície ocular para a língua portuguesa. Arq Bras Oftalmol 2012; 75: 24-28.
Beltrán F, Ramos Betancourt N, Martínez J et al., Mexican Ocular Surface Disease Study Group. Transcultural validation of Ocular Surface Disease Index (OSDI) questionnaire for Mexican population. Investig Ophthalmol Vis Sci 2013, 54: 6050.
Pakdel F, Gohari MR, Jazayeri AS et al. Validation of farsi translation of the Ocular Surface Disease Index. J Ophthalmic Vis Res 2017; 12: 301-304.
Rahman AAA, Badarudin NE, Azemin MZC, Arin AE. Development of a Bahasa Melayu version of Ocular Surface Disease Index (OSDI). Int J Allied Health Sci 2017; 1.
Lu F, Tao A, Hu Y et al. Evaluation of reliability and validity of three common dry eye questionnaires in Chinese. J Ophthalmol 2018; 2018: 2401213.
Frances M, Roa-Lingad RLBS. Cross-cultural adaptation and reliability of a Filipino dry eye screening questionnaire. Philipp J Ophthalmol 2018; 43: 65-71.
Midorikawa-Inomata A, Inomata T, Nojiri S et al. Reliability and validity of the Japanese version of the Ocular Surface Disease Index for dry eye disease. BMJ Open 2019; 9: e033940.
Zhao H, Liu Z, Yang W et al. [Development and assessment of a dry eye questionnaire applicable to the Chinese population]. Zhonghua Yan Ke Za Zhi 2015; 51: 647-654.
Simpson TL, Situ P, Jones LW, Fonn D. Dry eye symptoms assessed by four questionnaires. Optom Vis Sci 2008; 85: 692-699.
Vitale S, Goodman LA, Reed GF, Smith JA. Comparison of the NEI-VFQ and OSDI questionnaires in patients with Sjögren’s syndrome-related dry eye. Health Qual Life Outcomes 2004; 2: 44.
Chalmers RL, Begley CG, Caffery B. Validation of the 5-Item Dry Eye Questionnaire (DEQ-5): discrimination across self-assessed severity and aqueous tear deficient dry eye diagnoses. Cont Lens Anterior Eye 2010; 33: 55-60.
Okumura Y, Inomata T, Iwata N et al. A review of dry eye questionnaires: measuring patient-reported outcomes and health-related quality of life. Diagnostics (Basel) 2020; 10: 559.
Recchioni A, Aiyegbusi OL, Cruz-Rivera S et al. A systematic review assessing the quality of patient reported outcomes measures in dry eye diseases. PLoS One 2021; 16: e0253857.
Gomes JAP, Santo RM. The impact of dry eye disease treatment on patient satisfaction and quality of life: a review. Ocul Surf 2019; 17: 9-19.
Inomata T, Nakamura M, Iwagami M et al. Risk factors for severe dry eye disease: crowdsourced research using DryEyeRhythm. Ophthalmology 2019, 126: 766-768.
Rossi GCM, Tinelli C, Pasinetti GM et al. Dry eye syndrome-related quality of life in glaucoma patients. Eur J Ophthalmol 2009; 19: 572-579.
Dougherty BE, Nichols JJ, Nichols KK. Rasch analysis of the Ocular Surface Disease Index (OSDI). Invest Ophthalmol Vis Sci 2011; 52: 8630-8635.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Consejo Argentino de Oftalmología
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Con esta licencia no se permite un uso comercial de la obra original, ni la generación de obras derivadas. Las licencias Creative Commons permiten a los autores compartir y liberar sus obras en forma legal y segura.
